Lipoprotein mutations in pigs are associated with elevated plasma cholesterol and atherosclerosis.

A strain of pigs bearing three immunogenetically defined lipoprotein-associated markers (allotypes), designated Lpb5, Lpr1, and Lpu1, has marked hypercholesterolemia on a low fat, cholesterol-free diet. Unlike individuals with familial hypercholesterolemia or WHHL rabbits, the affected pigs have normal low density lipoprotein receptor activity. The animals, by 7 months of age, have extensive atherosclerotic lesions in all three coronary arteries. This strain of pig represents an animal model for atherosclerosis and hypercholesterolemia associated with mutations affecting the structures of plasma lipoproteins. One of the variant apolipoproteins, Lpb5, is apolipoprotein-B. A second variant apolipoprotein (Lpr1), termed apo-R, is a 23-kilodalton protein present in both the very low density (d less than 1.006 g/ml) and the very high density (d greater than 1.21 g/ml) fractions of pig plasma. Isoforms of this protein correlate with two Lpr alleles, Lpr1 and Lpr2. The Lpr genes segregate independently of the Lpb5 and Lpu1 alleles. The Lpu1 allotype is a component of low density lipoprotein and is genetically linked to Lpb5.

[1]  V. Schumaker,et al.  [6] Sequential flotation ultracentrifugation , 1986 .

[2]  V. Schumaker,et al.  Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Elson,et al.  Correlation of an immunogenetically defined lipoprotein type with aortic intimal lipidosis in swine. , 1977, Experimental and molecular pathology.

[4]  J. Rapacz,et al.  Lipoprotein immunogenetics and atherosclerosis. , 1978, American journal of medical genetics.

[5]  R. Jackson,et al.  Sulfhydryl chemistry and solubility properties of human plasma apolipoprotein B. , 1982, Biochemistry.

[6]  S. Young,et al.  Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Luginbühl,et al.  Coronary, aortic and cerebral atherosclerosis in swine of 3 age-groups: implications. , 1970, Bulletin of the World Health Organization.

[9]  T. Kita,et al.  Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia. , 1983, The New England journal of medicine.

[10]  W. A. Bradley,et al.  Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100 , 1986, Nature.

[11]  R H Haschemeyer,et al.  Oxygen-mediated heterogeneity of apo-low-density lipoprotein. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. French,et al.  Intimal changes in the arteries of ageing swine , 1963, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[13]  W. A. Bradley,et al.  Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences. , 1982, Biochemical and biophysical research communications.

[14]  J. Kane.  Apolipoprotein B: structural and metabolic heterogeneity. , 1983, Annual review of physiology.

[15]  V. Schumaker,et al.  Anti-apoprotein B monoclonal antibodies detect human low density lipoprotein polymorphism. , 1984, The Journal of biological chemistry.

[16]  J. Breslow,et al.  Human apolipoprotein B cDNA clone isolation and demonstration that liver apolipoprotein B mRNA is 22 kilobases in length. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Luginbühl,et al.  THE MORPHOLOGY AND MORPHOGENESIS OF ATHEROSCLEROSIS IN AGED SWINE * , 1965, Annals of the New York Academy of Sciences.

[18]  M. Brown,et al.  Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. , 1983, Methods in enzymology.

[19]  Fox Cf,et al.  Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril. , 1978 .

[20]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[21]  S. Naylor,et al.  Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Li,et al.  Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Hasler-Rapacz,et al.  Lipoprotein Immunogenetics in Primates. I. Two Serum β‐Lipoprotein Allotypes (Lmb1 and Lmb11) in Rhesus Monkeys and the LP‐B Immunological Relationship With Other Primates , 1982, Journal of medical primatology.

[24]  R. Eddy,et al.  Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization. , 1985, Science.

[25]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[26]  A. J. Valente,et al.  Properties of apolipoprotein B in urea and in aqueous buffers. The use of glutathione and nitrogen in its solubilization. , 1981, Biochimica et biophysica acta.

[27]  H. DeLuca,et al.  Multiple forms of vitamin D-dependent calcium-binding protein in rat kidney. , 1984, The Journal of biological chemistry.

[28]  A. Motulsky,et al.  A partial cDNA clone for human apolipoprotein B. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Mahley,et al.  Complete protein sequence and identification of structural domains of human apolipoprotein B , 1986, Nature.